Dan Wu

发表

Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised c

J. Ji, J. Suo, Yingwei Xue, 2021, The Lancet. Oncology.

Progress in research of postoperative nausea and vomiting after painless gastrointestinal endoscopy

Xin Liu, Dan Wu, 2021, World Chinese Journal of Digestology.

Effect of S-1 Plus Oxaliplatin Compared With Fluorouracil, Leucovorin Plus Oxaliplatin as Perioperative Chemotherapy for Locally Advanced, Resectable Gastric Cancer

Qi Zhang, Li Chen, Zekuan Xu, 2022, JAMA network open.

Perioperative chemotherapy of oxaliplatin combined with S-1 (SOX) versus postoperative chemotherapy of SOX or oxaliplatin with capecitabine (XELOX) in locally advanced gastric adenocarcinoma with D2 gastrectomy: A randomized phase III trial (RESOLVE trial)

Z. Li, Z. Zhou, Guoxin Li, 2019, Annals of Oncology.

Cytotoxic effect of different treatment parameters in pressurized intraperitoneal aerosol chemotherapy (PIPAC) on the in vitro proliferation of human colonic cancer cells

D. Díaz-Carballo, J. Zieren, T. Khosrawipour, 2017, World Journal of Surgical Oncology.

Erratum to: Cytotoxic effect of different treatment parameters in pressurized intraperitoneal aerosol chemotherapy (PIPAC) on the in vitro proliferation of human colonic cancer cells

D. Díaz-Carballo, A. Acikelli, J. Zieren, 2017, World Journal of Surgical Oncology.

Feasibility of Single Tumorspot Treatment in Peritoneal Carcinomatosis via Close Range Doxorubicin Impaction in Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC)

D. Díaz-Carballo, T. Khosrawipour, V. Khosrawipour, 2017 .

Efficacy and safety of ripretinib in Chinese patients with advanced gastrointestinal stromal tumors: a real-world, multicenter, observational study

Li-tao Yang, H. Qian, Lifeng Sun, 2023, Frontiers in Oncology.

A randomized, multicenter, controlled study to compare perioperative chemotherapy of oxaliplatin combined with TS-1 (SOX) versus SOX or oxaliplatin with capecitabine (XELOX) as post-operative chemotherapy in locally advanced gastric adenocarcinoma with D2 dissection (RESOLVE Trial).

J. Ji, Yingwei Xue, L. Shen, 2016 .

Adjuvant albumin-bound paclitaxel combined with S-1 vs. oxaliplatin combined with capecitabine after D2 gastrectomy in patients with stage III gastric adenocarcinoma: a phase III multicenter, open-label, randomized controlled clinical trial protocol

Ping Chen, Chang Wang, Wei Li, 2021, BMC cancer.